ABSTRACT
Background and Objective: Bioaerosols as small particles enter the body by inhalation and lead to respiratory diseases based on type, concentration, and exposure time. In sensitive workplaces such as medical centers, it is necessary to pay attention to the type and population of these pollutants and the possibility of nosocomial infections. In the present study, the population and type of bioaerosols (bacteria and fungi) in the air of different hospital wards under normal conditions, visiting hours, and Covid-19 pandemic was evaluated. Materials and Methods: Air sampling was carried out in different wards and ambient air of Valiasr Hospital of Zanjan during September 2019 (morning and visiting hours) and October 2020 (Corona pandemic) using an air sampling pump (Flite 3-SKC Ltd) with a flow of 14.1 L/min and then cultured in Sabaroud dextrose agar and nutrient agar. Results: The results showed that air pollution in wards such as infectious diseases and clinics in both periods was more than other wards. The microbial density during visiting hours (before the coronavirus outbreak) was almost 30% higher than normal conditions. In October 2020, due to the coronavirus outbreak and reduced traffic, microbial air pollution in the hospital decreased. In both periods of study, the frequency of gram-positive bacteria, especially Staphylococcus species (49%) was higher than other bacteria and among fungal species the frequency of Aspergillus (47%) was higher than others. Conclusion: This study showed that traffic restrictions caused by the coronavirus pandemic reduce microbial density in hospital space and this achievement can be used in the future with the aim of improving air quality and controlling nosocomial infections. © 2022 Iranian Association of Environmental Health, and Tehran University of Medical Sciences.
ABSTRACT
OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a debilitating disease with numerous medical and non-medical consequences. Our study aimed to evaluate the efficacy of Persian barley water in controlling the clinical outcomes of hospitalized COVID-19 patients. PATIENTS AND METHODS: This was a single-blind, add-on therapy, randomized controlled clinical trial conducted in Shiraz, Iran, from January to March 2021. One hundred hospitalized COVID-19 patients with moderate disease severity were randomly allocated to receive routine treatment (per local protocols) with or without 250 ml of Persian barley water (PBW) daily for two weeks. Clinical outcomes and blood tests were recorded before and after the study period. Multivariable modeling was applied using Stata software for data analysis. RESULTS: The PBW product passed our standardization and safety assessments. Length of hospital stay (LHS) was 4.5 days shorter in the intervention group than the control group regardless of history of cigarette smoking (95% confidence interval: -7.22, -1.79 days). Also, body temperature, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and creatinine significantly dropped in the intervention group compared to the control group. No adverse events related to PBW occurred. CONCLUSIONS: This clinical trial demonstrated the efficacy of PBW in minimizing the LHS, fever, and levels of ESR, CRP, and creatinine among hospitalized COVID-19 patients with moderate disease severity. More robust trials can help find safe and effective herbal formulations as treatments for COVID-19.
Subject(s)
COVID-19/therapy , Hordeum , Medicine, Persian/methods , Adult , Aged , Blood Sedimentation/drug effects , C-Reactive Protein/drug effects , Creatinine , Fever/therapy , Hospitalization , Humans , Length of Stay , Male , Middle Aged , Severity of Illness Index , Single-Blind Method , Treatment OutcomeABSTRACT
Introduction: To date, little is known about the clinical features of pediatric COVID-19 patients admitted to intensive care units (ICUs). Objective: Herein, we aimed to describe the differences in demographic characteristics, laboratory findings, clinical presentations, and outcomes of Iranian pediatric COVID-19 patients admitted to ICU versus those in non-ICU settings. Methods: This multicenter investigation involved 15 general and pediatrics hospitals and included cases with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on positive real-time reverse transcription polymerase chain reaction (RT-PCR) admitted to these centers between March and May 2020, during the initial peak of the COVID-19 pandemic in Iran. Results: Overall, 166 patients were included, 61 (36.7%) of whom required ICU admission. The highest number of admitted cases to ICU were in the age group of 1–5 years old. Malignancy and heart diseases were the most frequent underlying conditions. Dyspnea was the major symptom for ICU-admitted patients. There were significant decreases in PH, HCO3 and base excess, as well as increases in creatinine, creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and potassium levels between ICU-admitted and non-ICU patients. Acute respiratory distress syndrome (ARDS), shock, and acute cardiac injury were the most common features among ICU-admitted patients. The mortality rate in the ICU-admitted patients was substantially higher than non-ICU cases (45.9% vs. 1.9%, respectively;p<0.001). Conclusions: Underlying diseases were the major risk factors for the increased ICU admissions and mortality rates in pediatric COVID-19 patients. There were few paraclinical parameters that could differentiate between pediatrics in terms of prognosis and serious outcomes of COVID-19. Healthcare providers should consider children as a high-risk group, especially those with underlying medical conditions. © 2021 Tehran University of Medical Sciences.